Status:

COMPLETED

Assessment of Efficacy and Safety of Olmesartan Medoxomil in Children and Adolescent Patients With High Blood Pressure

Lead Sponsor:

Daiichi Sankyo

Conditions:

Hypertension

Eligibility:

All Genders

1-16 years

Phase:

PHASE2

PHASE3

Brief Summary

This study assesses the efficacy and safety of olmesartan medoxomil in children ages 1-16 with high blood pressure. After a 5-week blinded treatment period of up to 5 weeks participants can continue t...

Detailed Description

This was a randomized, multicenter, double-blind, parallel-group, prospective dose-ranging study in subjects 1 to 16 years of age with hypertension. Subjects were enrolled into 1 of 3 cohorts based on...

Eligibility Criteria

Inclusion

  • The patient's seated systolic BP (SeSBP) will be greater than or equal to 95th percentile for gender and height-for- age, or greater than or equal to 90th percentile if the patient is diabetic, or has glomerular kidney disease, or has a family history of hypertension.
  • Negative for hepatitis B and C
  • Negative for HIV

Exclusion

  • Patient should not have serious other conditions that could interfere with the analysis of the results or that could interfere with the well-being of the patient in the trial.
  • Known sensitivity to olmesartan medoxomil
  • Taking prohibited medication
  • Consumed greater than 180 mg of caffeine daily
  • Malignant hypertension
  • History of congestive heart failure, cardiomyopathy, or obstructive valve disease
  • Renal transplant within the previous 6 months
  • Severe nephritic syndrome not in remission

Key Trial Info

Start Date :

May 1 2005

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

September 1 2008

Estimated Enrollment :

362 Patients enrolled

Trial Details

Trial ID

NCT00151775

Start Date

May 1 2005

End Date

September 1 2008

Last Update

June 30 2016

Active Locations (65)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 17 (65 locations)

1

Birmingham, Alabama, United States

2

Phoenix, Arizona, United States, 85013

3

Little Rock, Arkansas, United States

4

Beverly Hills, California, United States